Search

everythinglearnresearchcommunity

for

Search:↓

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Upadacitinib may effectively treat alopecia areata without side effects.

Postmenopausal women with excess male hormones may have ovarian tumors, and surgery usually cures them.

A woman died from cancer that spread from a long-standing cyst on her abdomen.

Mutations in certain receptors can cause diseases and offer new treatment options.

Postmenopausal hyperandrogenism involves excess male hormones causing symptoms like hair growth and acne, and requires ruling out tumors and other disorders.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Oestrogen does not affect adrenal androgen levels in children and adolescents.

Cronkhite-Canada syndrome is rare, with high mortality and cancer risk, needing more research for treatment guidelines.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Chemotherapy for male germ cell tumors often leads to hypogonadism and related symptoms.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

Gastric bypass surgery improved a woman's hormonal disorder without the need for medication.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Steroid cell tumors in the ovary are rare, can produce testosterone causing symptoms, and are mainly treated with surgery.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

A combination of ciclosporin and ketoconazole can effectively treat severe hair loss in dogs.

Hair root analysis can effectively detect somatic mosaicism in double cortex syndrome.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.